At What Cost?: Egregious Price Increases in the Pharmaceutical Drug Industry
106 Dirksen Senate Office Building
July 24, 2008
U.S. Senator Amy Klobuchar (D-MN) convened a hearing of the Joint Economic Committee (JEC) to examine the skyrocketing prices of certain prescription drugs and the impact on the pharmaceutical market, hospital’s budgets and patient’s medical bills. The hearing entitled, "At What Cost?: Egregious Price increases in the Pharmaceutical Drug Industry" was held Thursday, July 24 at 10am in Room 106 of the Dirksen Senate Office Building. Senator Charles E. Schumer, Chairman of the Joint Economic Committee, has been a staunch advocate of lower priced drugs and a competitive pricing market. The panel of experts explored the causes of recent price increases for treatments for rare diseases and the negative impact on affected families’ fiscal stability and access to care.